BlueWillow Biologics, Inc. Employee Directory
Biotechnology ResearchMichigan, United States11-50 Employees
BlueWillow Biologics, Inc. is a privately held biotechnology research company headquartered in Ann Arbor, Michigan. It develops intranasal vaccines based on a patented adjuvant platform intended to generate immune responses both in the bloodstream and at mucosal surfaces. Its lead programs target pathogens such as RSV, influenza, pertussis, anthrax, HSV-2 and chlamydia. The company operates in the biotechnology sector, seeking to address gaps in mucosal immunity through nasal vaccines. In September 2022, BlueWillow Biologics was acquired by LimeWire GmbH.